This was stated by Leo in the 12/26 PR about the U
Post# of 72440
The only positive outcome for the company that I can come up with is a deal. Anybody got any other ideas?
“The study is expected to be a quick one, with dosing completed within several weeks of commencement, and, if successful, would translate into numerous potential positive outcomes for the company,” noted Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals.